Axial Biotech
2749 E. Parley
Salt Lake City
UT
84109
801-478-1650

Axial Biotech, Inc. is focused on the use of genetics and the development of minimally invasive, motion preserving implants to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is the first company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices.

Deal Flow

Fundings

Closing Date Round Amount
03/17/2008 Unattributed $7,000,000
03/01/2008 Series B $6,000,000
10/01/2006 Unattributed $650,000
01/01/2005 Series A $4,100,000

Mergers & Acquisitions

Public Offerings

Press

Company Video

Company Snapshot

Yes
Biotechnology | Diagnostics
2003
Active
Not Assigned
$750,000
$26,050,000
Link
Link
20
20
2009 Innovation Award

Key People

Similar Companies


Legal Disclaimer